SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Georgia O'Keeffe

PatientGeorgia O'Keeffe
Date of birth1945-11-15
IdentifiersMRN HR-ET011-SYN; SSN (made up) 000-11-5873
Document date2026-05-07
AuthorWendell Ashby, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Third loading injection and end-of-loading review, left eye. [S]

History of Present Illness

Ms. O'Keeffe returns four weeks after her second injection, eight weeks after starting treatment. Straight lines look nearly straight again with the left eye, and she can read newspaper headlines and judge color in the studio better than in March. She has had no pain, redness, or loss of vision after either injection. Daily Amsler checks show no change in the right eye. She takes the AREDS2 supplement daily. Her low-vision rehabilitation evaluation took place this month, and the home visit and driving assessment are under way. [S]

ElementDetail
Interval changeDistortion nearly gone in the left eye; color judgment better
Injection toleranceNo pain, redness, or vision loss after two injections
Amsler gridDaily checks; right eye unchanged
Low-vision rehabilitationEvaluation done; home visit and driving assessment under way

Review of Systems

SystemResultFinding
EyesPositiveSlight residual blur in the left eye; no pain, flashes, or floaters
ConstitutionalNegativeWeight stable; good energy
MusculoskeletalNegativeNo falls
PsychiatricNegativeMood good; painting daily

4 systems reviewed. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-05-07Body height165cmS
2026-05-07Body weight56kgS
2026-05-07Body mass index (BMI) [Ratio]20.6kg/m2S
2026-05-07Systolic blood pressure126mm[Hg]S
2026-05-07Diastolic blood pressure70mm[Hg]S
2026-05-07Heart rate68/minS
2026-05-07Respiratory rate14/minS
2026-05-07Body temperature36.6CelS
2026-05-07Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-07Visual acuity best corrected Left eye by ETDRS eye chart69{letters}>=80LowS
2026-05-07Macular grid.center subfield thickness by OCT274um200-300 umNormalS
2026-05-07Left eye Intraocular pressure14mm[Hg]10-21 mmHgNormalS

Physical Exam

Vital signs recorded on 2026-05-07; see the Vital Signs section. [S]

SystemFinding
Visual acuityBest-corrected 69 letters left, up from 55
Intraocular pressure14 mmHg left before injection
Anterior segmentQuiet
Dilated fundus, left eyeLesion flat, with no fluid or hemorrhage
Dilated fundus, right eyeLarge drusen unchanged; no fluid or hemorrhage
OCT, left eyeDry macula; central subfield thickness 274 µm
After injection, left eyeOptic nerve head perfused; counts fingers; no pain

Problems

ProblemClinical statusVerificationCodeProvenance
Neovascular (wet) age-related macular degeneration, left eye, with active choroidal neovascularizationactiveconfirmed H35.3221S — Synthetic modern diagnosis linked to her documented failing eyesight; the historical type of macular degeneration is not recorded.
Nonexudative age-related macular degeneration, right eye, intermediate stageactiveconfirmed H35.3112S — Synthetic finding in the fellow eye.
New distortion (wavy lines) and a blurred central spot with reduced acuity in the left eye; suspected neovascular macular degeneration, urgent retina referralresolvedconfirmed H53.15S — Synthetic presenting concern at the index visit, superseded by the OCT diagnosis at the retina consultation; her failing eyesight is documented (D).

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBest-corrected visual acuity (ETDRS letters)Every injection visitCompleted todayLeft 69 letters, up 14 from baseline; loading goal met
ImagingOptical coherence tomography of the maculaEvery injection visitCompleted todayLeft eye dry; central subfield thickness 274 µm
ExaminationIntraocular pressure before and after injectionEvery injection visitCompleted todayBefore injection 14 mmHg left; after injection, optic nerve perfused and counting fingers
ExaminationDilated examination of the fellow (right) eyeEvery injection visitCompleted todayLarge drusen unchanged; no fluid
Medication safetyIntravitreal injection safetyEvery injection visitCompleted todayNo complication after three injections; last loading dose today
Self-managementTeaching on warning signs of endophthalmitis and retinal detachmentEvery injection visitCompleted todayReviewed again before the longer interval
Self-managementDaily home Amsler grid, each eyeDailyCompleted todayDaily checks recorded; no change in the right eye
Medication safetyAREDS2 supplement for intermediate AMDDaily, long termCompleted todayTaking it daily
ReferralLow-vision rehabilitation, with home fall-risk review and a driving assessmentOnce central vision is reduced; review as vision changesReferredEvaluation done this month; home visit and driving assessment under way
SurveyDepression screen (PHQ-2)At follow-up, because vision loss raises the risk of depression; periodically at 65 or olderDuePlanned at the July primary care review

Goal progress:

Guideline basis: Age-Related Macular Degeneration Preferred Practice Pattern (2024); CMID: Clinical Monitoring Intelligence Database, cataract and glaucoma monographs (eye-examination items) (2026)

Follow-up: Retina visit in eight weeks, with the primary care review of vision rehabilitation on the same day. Next scheduled visit 2026-07-02: treat-and-extend retina visit and primary care review of vision rehabilitation. [S]